These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15470274)

  • 1. Cardiovascular effects of HAART in infants and children of HIV-infected mothers.
    Zareba KM; Lavigne JE; Lipshultz SE
    Cardiovasc Toxicol; 2004; 4(3):271-9. PubMed ID: 15470274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study.
    Lavigne JE; Shearer WT; Thompson B; Orav EJ; Starc TJ; Colan SD; Pignatelli R; O'Brien SE; Bezold L; LaRusa P; Easley KA; Cheng I; Duffy SA; Lipshultz SE;
    Cardiovasc Toxicol; 2004; 4(2):187-97. PubMed ID: 15371634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No relation between in-utero exposure to HAART and intrauterine growth retardation.
    Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
    AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
    Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.
    Jitratkosol MH; Sattha B; Maan EJ; Gadawski I; Harrigan PR; Forbes JC; Alimenti A; van Schalkwyk J; Money DM; Côté HC;
    AIDS; 2012 Mar; 26(6):675-83. PubMed ID: 22436539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers.
    Bunders MJ; Bekker V; Scherpbier HJ; Boer K; Godfried M; Kuijpers TW
    Acta Paediatr; 2005 Nov; 94(11):1571-7. PubMed ID: 16303696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.